PROGERIA

Clinical trials for PROGERIA explained in plain language.

Never miss a new study

Get alerted when new PROGERIA trials appear

Sign up with your email to follow new studies for PROGERIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug combo aims to slow Progeria's effects

Disease control ENROLLING_BY_INVITATION

This study tests whether adding everolimus to the existing drug lonafarnib can better control progeria, a rare disease that causes rapid aging in children. About 80 children with confirmed progeria will take both pills by mouth. The first part finds the safest dose of everolimus,…

Matched conditions: PROGERIA

Phase: PHASE1, PHASE2 • Sponsor: Boston Children's Hospital • Aim: Disease control

Last updated Jun 27, 2026 12:03 UTC

PROGERIA

Get alerted when new PROGERIA trials appear

New drug combo aims to slow Progeria's effects